XLone-Puro CCND2-T2A-luciferase-P2A-eGFP Citations (1)
Originally described in: Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study.Joshi J, Xu B, Rubart M, Chang Y, Bao X, Chaliki HP, Scott LR, Zhu W Cells. 2022 Mar 10;11(6). pii: cells11060951. doi: 10.3390/cells11060951. PubMed Journal
Articles Citing XLone-Puro CCND2-T2A-luciferase-P2A-eGFP
| Articles |
|---|
| Capacity for Compensatory Cyclin D2 Response Confers Trametinib Resistance in Canine Mucosal Melanoma. Wei BR, Verdi V, Zhang S, Mock BA, Shive HR, Simpson RM. Cancers (Basel). 2025 Jul 15;17(14):2357. doi: 10.3390/cancers17142357. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.